Table 2.
Disease | Research object | in vitro in vivo |
administration route | Mechanism of action | Results | Refs |
---|---|---|---|---|---|---|
AD and PD | Protein tau | in vitro | - | ↓the aggregation and oligomerization of tau | Inhibited the aggregation of tau and dissolved the tau aggregates | [88] |
AD | N2a/WT cells, N2a/ APP695swe cell and six-month-old APP/PS1 double transgenic mice | in vitro in vivo |
p.o. | ↓Caveolin-1↓ GSK-3β | Attenuate the hyper-phosphorylation of Tau | [89] |
AD | SH-SY5Y (human neuroblastoma cells) and HEK293 (human kidney cells) | in vitro | - | ↑ERβ directly effects on the upstream factors of the NFκB signaling pathway | Notably reduce Aβ levels and inhibits BACE1gene expression | [90] |
AD | Adult male and female APPswe/PS1dE9 mice | in vivo | i.v. | ↓amyloid deposition ↓Aβ aggregation ↓soluble Aβ40 ↑ oluble Aβ42 | Reverses existing amyloid pathology and associated neurotoxicity | [91] |
AD | Tg2576 mice (B6; SJLTg (APPSWE) 2576Kh) with the APP Swe transgene); THP-1 cells | in vitro in vivo |
p.o. | ↓ CD33↑TREM2 ↑ TyroBP ↓miR-155↓genes characteristic of toxic pro-inflammatory M1 microglia (CD11b, iNOS, COX-2, IL-1β) | Stimulate phagocytic clearance of amyloid while restore neuro-inflammatory networks | [92] |
AD | Amyloid-β (Aβ1 -40) induced AD rat models | in vivo | i.p. | ↓GFAP mRNA and the number of GFAP positive cells ↓AS activity | Improves the spatial memory disorders in Aβ1-40-induced rats | [93] |
AD | APPswe/PS1 dE9 double transgenic mice | in vivo | i.g. | ↑ insulin like growth factor (IGF)-1R, IRS-2, PI3K, p-PI3K, Akt and p-Akt protein expression ↓ IR and IRS-1 | Improve spatial learning and memory by increasing glucose metabolism and ameliorating the impaired insulin signalling pathways in the brain | [95,96] |
PD | An PD mice model induced by rotenone | in vivo | p.o. | ↑mitochondrial enzyme complex activities ↓acetylcholine esterase enzyme level ↑activities of antioxidant enzymes | Improve behavioral alterations and have antioxidant potential in vivo. | [97] |
PD | Transgenic fly lines that express wild-type human synuclein (h-αS) | in vivo | p.o. | ↓lipid peroxidation ↓protein carbonyl content↓mean gray scale values | Improve the loss of activity pattern, reduce the oxidative stress and apoptosis, and prolong lifespan to a certain extent. | [98] |
PD | Adult male C57BL/6 mice; Mouse brain and the 1RB3AN27 (N27) rat dopaminergic neuronal cell line | in vitro in vivo |
i.p. | ↑GSH levels ↑ γ-GCL gene expression ↑ formation of the EpRE complex and the AP1 transcription factor | Protects mouse brain against GSH depletion-mediated oxidative stress in vivo and in vitro | [99] |
PD | A 6-Hydroxydopmine-Induced Rat Model of PD | in vivo | p.o. | ↑the function of α7-nAChRs expressed | Neuroprotective effect via an α7-nAChR-mediated mechanism. | [100] |
PD | A rat model of PD induced by LPS | in vivo | i.p. | ↓transcription factor NFjB ↓proinflammatory cytokines (TNF-α, IL-1β, and IL-1α) ↓inducible nitric oxide synthase (iNOS)↓ regulating molecules of the intrinsic apoptotic pathway (Bax, Bcl-2, Caspase 3 and Caspase 9) | Modulate the aggregation of a-synuclein in vitro and in vivo. | [101] |
PD | Male, albino, NMRI rats brain mitochondria | in vitro | - | Preventing mitochondrial HKI release and ROS enhancement induced by α-synuclein fibrillation products | Ameliorate neurodegenerative disorders in PD. | [102] |
PD | SH-SY5Y cells | in vitro | - | ↓phosphor-mTOR and phosphor-p70S6K↓the accumulation of A53T α-synuclein | Reduce the accumulation of A53T α-synuclein through the mTOR/ p70S6K signaling and recovery of macroautophagy | [103] |
PD | 6-hydroxydopamine (6-OHDA)-PD rat model | in vivo | p.o. | ↑ hippocampal brain derived neurotrophic factor (BDNF), ↑TrkB, ↑phospha-tidylinositide 3-kinases (PI3K) | Promoting neural regeneration of hippocampal tissue | [104] |
PD | SH-SY5Y neuroblastoma cells knocked down of PINK1 via siRNA | in vitro | - | ↑ cell viability and maximal respiration ↑mitochondrial membrane potential (MMP)↓apoptosis | Prevent mitochondrial dysfunction and apoptosis in PINK1-deficient cells. | [105] |
Depression | Chronic unpredictable mild stress (CUMS)-induced depression rat model | in vivo | p.o. | ↓NF-κB P65↑IkB↓ IL-1β, IL-6 and TNF-α↓P2X7R, NLRP3, and Caspase-1 P20↓pro-IL-1β and mature-IL-1β↓indolamine-2, 3-dioxygenase (IDO) expression↓KYN content and the KYN/TRP ratio↑5-HT content | Alleviate depression by inhibiting the NLRP3 inflammasome and kynurenine pathway. | [106] |
post-stroke depression (PSD) | SD rats of PSD model | in vivo | p.o. | ↓Ca2+channel ↓P2X7R ↓TNF-α ↓IL-1β | Block Ca2+ accumulation and neuroinfammation by inhibit P2X7R activity | [107] |
Depression | CUMS-induced depression rat model | in vivo | i.p. | ↓Iba-1↓GFAP↓IL-1β ↓TUNEL positive cell ↑NeuN positive cell | Alleviated depression-like behaviors, expression of the proinflammatory cytokine interleukin-1β (IL-1β) and inhibited neuronal apoptosis within neurons of the ventromedial prefrontal cortex (vmPFC) | [108] |
Depression | CUMS-induced depression rat model | in vivo | p.o. | ↓oxidative stress markers (Nox2, 4-HNE, and MDA) ↑ activity of CAT ↑mRNA expression of NQO-1 and HO-1 | Curcumin could alleviate the oxidative stress via Nrf2-ARE signaling pathway to improve depressive-like state. | [109] |
Depression | Adult rats exposed to a regime of chronic stress | in vivo | p.o. | ↑5-HT1A mRNA and BDNF protein levels | Increased hippocampal neurogenesis in chronically stressed rats, prevented the stress-induced decrease in 5-HT1A mRNA and BDNF protein levels in the hippocampal subfields | [110] |
Depression | Adult male Wistar Kyoto (WKY) rat, a putative model of depression | in vivo | i.p. | Reduction of immobility in the forced swim test (FST); increase in hippocampal brain derived neurotrophic factor (BDNF) | Antidepressant-like effect by increased neurotrophic activity | [111] |
Depression | CUMS-induced depression rat model | in vivo | i.p. | ↑expression of synapse-associated proteins (such as brain-derived neurotrophic factor, PSD-95 and synaptophysin)and LA synaptophysin | Neuroprotection and antidepressant-like effects in the CUMS induced depression model. | [112] |
Depression | Olfactory bulbectomy and forced swimming test models of depression in male albino rats | in vivo | p.o. | ↑serotonin, dopamine, and noradrenaline ↓3, 4-dihydroxyphenylacetic acid and 5-hydro-xyindoleacetic acid | Exert antidepressant activity in the olfactory bulbectomy and forced swim test model of depression through monoaminergic neurotransmitter pathway | [113] |